¼¼°èÀÇ »ýü º¸Ã¶ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¿¹Ãø(2025-2032³â)
Bioprosthetics Market, By Product, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1808953
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 311 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,605,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,589,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,006,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»ýü º¸Ã¶ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 59¾ï 4,800¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 4.80%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»ýü º¸Ã¶Àº º¸Ã¶ ÀåÄ¡ÀÇ Á¦Á¶¿¡ »ý¹°ÇÐÀû Àç·á¸¦ »ç¿ëÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±¸´Â º¸Åë ¼Õ»óµÇ°Å³ª ´©¶ôµÈ ½Åü ºÎÀ§ÀÇ ´ëü ¹× ±â´É ȸº¹À» ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ÇÃ¶ó½ºÆ½À̳ª ±Ý¼Ó µîÀÇ ÇÕ¼º Àç·á·Î ¸¸µé¾îÁø ±âÁ¸ÀÇ Àΰø Àåºñ¿Í´Â ´Þ¸®, »ýü º¸Ã¶Àº Á¶Á÷À̳ª »ýü Àç·á µîÀÇ Ãµ¿¬ ¿ä¼Ò¸¦ µµÀÔÇÏ¿© ÀÎü ºÎºÐÀÇ ±â´É°ú ±¸Á¶¸¦ ´õ Àß ¸ð¹æÇϰí ÀÖ½À´Ï´Ù.

»ýü º¸Ã¶ ½ÃÀå - ½ÃÀå ¿ªÇÐ

Àç»ý ÀÇ·á Á¢±Ù¹ýÀÇ Áøº¸

Àç»ý ÀÇ·áÀÇ ±Þ¼ÓÇÑ Áøº¸°¡ ƯÈ÷ Áٱ⠼¼Æ÷ Ä¡·á ¹× Á¶Á÷ °øÇаú °°Àº »ýü º¸Ã¶ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº õ¿¬ Á¶Á÷°ú ¸Å¿ì À¯»çÇÑ »ýü º¸Ã¶ ÀåÄ¡¸¦ ¸¸µé ¼ö ÀÖÀ¸¸ç ÅëÇÕ¼º, ±â´É¼º ¹× ȯÀÚÀÇ Àå±â °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 10¿ù, ¿¬±¸ÀÚµéÀº Áٱ⼼Æ÷ À¯·¡ÀÇ Ä¡·á¹ýÀ» ÀÌ¿ëÇÏ¿© ³ëÀÎȲ¹Ýº¯¼ºÀÇ Ä¡·á¿¡ ¼º°øÇÏ¿© ȯÀÚÀÇ ½Ã·ÂÀ» Å©°Ô °³¼±Çß½À´Ï´Ù. ÀÌ È¹±âÀûÀÎ ¼º°ú´Â ±â´ÉÀ» ȸº¹ÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â »ýü º¸Ã¶ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâÀ§ÇÑ Àç»ý Á¢±ÙÀÇ °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù. Àç»ý ÀÇÇÐÀÌ Áøº¸ÇÔ¿¡ µû¶ó »ýü º¸Ã¶ ÀÓÇöõÆ®ÀÇ ¼º´É°ú ¼ö¸íÀ» Çâ»ó½ÃŰ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ°Ô µÇ¾î ½ÃÀå ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ýü º¸Ã¶ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ »ýü º¸Ã¶ ½ÃÀåÀº Á¦Ç°, ¿ëµµ, Áö¿ª¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.

½ÃÀåÀº Á¦Ç°¿¡ µû¶ó µ¿Á¾ ÀÌ½ÄÆí°ú ÀÌÁ¾ ÀÌ½ÄÆíÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í µ¿Á¾ÀÌ½Ä ¼ö¼úÀÇ Áøº¸·Î µ¿Á¾ÀÌ½Ä ºÐ¾ß°¡ 2025³â ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. µ¿Á¾ À̽ÄÀº ÇÑ °³Ã¼¿¡¼­ ´Ù¸¥ µ¿Á¾ °³Ã¼·ÎÀÇ Á¶Á÷°ú ±â°üÀÇ À̽ÄÀÔ´Ï´Ù. ¼¼°èÀÇ ³ëÈ­´Â CVD Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç Á¶Á÷ÀÇ º¹±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. µ¿Á¾ ÀÌ½Ä Àΰø °üÀýÀº ¶Ù¾î³­ ÀÌ½Ä »ýÁ¸ ±â°£°ú ±â´ÉÀû ¼º´ÉÀ¸·Î µÎµå·¯Á® Àå±âÀûÀÎ °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ¿¹¸¦ µé¾î, Artivion, Inc.ÀÇ CryoValve AORTIC ALLOGRAFT´Â ¿ÏÀüÇÑ ´ëµ¿¸Æ ±âÀúºÎ»Ó¸¸ ¾Æ´Ï¶ó Á¦°øµÈ ½Â¸ðÆÇ Àü¿±À» Æ÷ÇÔÇÏ¸ç ¿©·¯ ¼ö¼ú ÀÌ½Ä ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó ½ÉÀåÇ÷°ü ºÐ¾ß¿Í ¼ºÇü ¼ö¼ú, »óó Ä¡À¯ ºÐ¾ßÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¼ºÇü ¼ö¼ú ¹× »óó Ä¡À¯ ºÐ¾ß´Â ³·Àº ħ½À ¼ö¼ú ¼ö¿ä Áõ°¡¿Í ±â¼ú Áøº¸·Î ¿¹Ãø ±â°£ µ¿¾È ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ì±¹ ¼ºÇü¿Ü°úÇÐȸ(ASPS)¿¡ µû¸£¸é, ³²¼º¿¡°Ô ÇàÇØÁø ¹Ì¿ë ¼ºÇü ¼ö¼úÀº ÀüüÀûÀ¸·Î 6% Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ, ³·Àº ħ½À ±â¼úÀÇ µµÀÔÀº ºÎ¹®ÀÇ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ 2023³â ASPS Procedural Statistics¿¡ µû¸£¸é ¹Ì¿ë ¼ºÇü ¼ö¼úÀÇ Àü¹ÝÀûÀÎ ¼ºÀåÀº ¿¬°£ 5% Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

»ýü º¸Ã¶ ½ÃÀå - Áö¸®Àû ÅëÂû

2025³â¿¡´Â ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î´Â ½ÉÇ÷°ü Áúȯ·üÀÇ »ó½ÂÀ̳ª ÀÌ Áö¿ªÀÇ ÀÇ·á½Ã¼³ÀÇ È®¸³ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹ Áúº´°ü¸®¿¹¹æ¼¾ÅÍ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿©ÀüÈ÷ ½ÉÇ÷°üÁúȯ(CVD)ÀÌ °øÁßÀ§»ý»óÀÇ Å« ¹®Á¦°¡ µÇ°í ÀÖÀ¸¸ç, 33ÃÊ¿¡ ÇÑ ¸íÀÌ CVD¿¡¼­ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿ì·ÁÇÒ¸¸ÇÑ Åë°è´Â ½ÉÀåÇ÷°ü ºÎ¹®¿¡¼­ ´õ ³ªÀº »ýü Àΰø ½ÉÀå ÆÇ¸· ¼±ÅÃÀÇ Çʿ伺À» µ¸º¸À̰ÔÇÕ´Ï´Ù. ¹Ì±¹ ½ÃÀåÀº ºÏ¹ÌÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ½ÉÀå Áúȯ Áõ°¡, °Ç°­ °ü¸® ÁöÃâ Áõ°¡, ÀÌ ³ª¶óÀÇ ÁÖ¿ä ¹ÙÀÌ¿ÀÆÄ¸Ó ±â¾÷¿¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥°ú ´ë±Ô¸ð R&D ÅõÀÚ°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGRÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±Þ¼ºÀåÀÇ ¹è°æÀº ´ëüġ·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ±Þ¼ÓÇÑ ¹ßÀü, Àεµ¿Í Áß±¹ µî ½ÅÈï ±¹°¡¿¡¼­ÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ³ë·ÂÀÇ È°¼ºÈ­°¡ ÀÖ½À´Ï´Ù. ÀÌµé ±¹°¡ÀÇ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÇ·á Á¢±Ù¼º°ú Áú Çâ»óÀ» ¸ñÇ¥·Î Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Áö¿ªÀÇ ¼ºÀå °¡´É¼ºÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Áß±¹ÀÇ '°Ç°­ Áß±¹ 2030' °èȹÀº °Ç°­ ÁõÁø°ú Àå¼ö ÃËÁøÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº »ýü º¸Ã¶°ú °°Àº ¼±Áø ÀÇ·á ±â¼úÀÇ Ã¤ÅÃÀ» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù.

»ýü º¸Ã¶ ½ÃÀå - °æÀï ±¸µµ :

»ýü º¸Ã¶ ½ÃÀåÀº ±â¼ú Çõ½Å, Àç·á Áøº¸, ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °æÀïÀÌ Ä¡¿­ ÇØÁö°í ÀÖ½À´Ï´Ù. LeMaitre Vascular, Inc., Braile Biomedica, Medtronic, Rua Life Sciences Plc(Aortech International Plc.), LivaNova PLC(Sorin Group)´Â ´Ù¾çÇÑ »ýü ¹ëºê ¹× Àΰø Ç÷°ü Æ÷Æ®Æú¸®¿À¿¡¼­ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº R&D ÅõÀÚ, Àü·«Àû Àμö, ½ÃÀå ÁöÀ§ °­È­¸¦ À§ÇÑ ¼¼°è °³¹ßÀ» ÅëÇØ °æÀïÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î ±â¾÷°ú ½Å±Ô ±â¾÷Àº Çõ½ÅÀûÀÎ Á¶Á÷ °øÇÐ ÀÓÇöõÆ®¿Í °³º°È­µÈ »ýü º¸Ã¶ ¼Ö·ç¼ÇÀ¸·Î ½ÃÀå¿¡ ÁøÃâÇϰí ÀÖ½À´Ï´Ù. °æ Ä«Å×ÅÍ ´ëµ¿¸Æ ÆÇ¸· ġȯ¼ú(TAVR)ÀÇ »ç¿ë Áõ°¡, ±ÔÁ¦ ´ç±¹ÀÇ È£ÀÇÀûÀÎ ½ÂÀÎ, ½ÉÇ÷°ü Áúȯ ¹× Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ¾÷°è °æÀïÀ» °ÝÈ­½ÃŰ°í ±â¼ú Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå »ýü º¸Ã¶ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ýü º¸Ã¶ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå »ýü º¸Ã¶ »ê¾÷ Á¶»ç

Á¦5Àå »ýü º¸Ã¶ ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

Á¦6Àå »ýü º¸Ã¶ ½ÃÀå »óȲ

Á¦7Àå »ýü º¸Ã¶ ½ÃÀå - Á¦Ç°º°

Á¦8Àå »ýü º¸Ã¶ ½ÃÀå - ¿ëµµº°

Á¦9Àå »ýü º¸Ã¶ ½ÃÀå - Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - »ýü º¸Ã¶ ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§Àû Àü¸Á

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Bioprosthetics Market size was valued at US$ 5,948 Million in 2024, expanding at a CAGR of 4.80% from 2025 to 2032.

Bioprosthetics is the use of biological materials in the manufacture of prosthetic devices. These devices are usually intended to replace or restore the functionality of damaged or missing body parts. Unlike traditional prosthetics, which are typically made of synthetic materials such as plastics or metals, bioprosthetics incorporate natural elements such as tissues or biomaterials to better mimic the function and structure of human body parts.

Bioprosthetics Market- Market Dynamics

Advances in regenerative medicine approaches

Rapid advances in regenerative medicine are driving innovation in bioprosthetics, particularly stem cell therapy and tissue engineering. These techniques enable the creation of bioprosthetic devices that closely resemble natural tissues, thereby improving integration, functionality, and long-term patient outcomes. For instance, in October 2024, researchers successfully used stem cell-derived therapies to treat age-related macular degeneration, significantly improving patients' vision. This breakthrough demonstrates the potential of regenerative approaches for developing bioprosthetic solutions that restore function and improve quality of life. As regenerative medicine advances, it is expected to play an important role in improving the performance and longevity of bioprosthetic implants, thereby driving market growth.

Bioprosthetics Market- Key Insights

Our research analyst estimates that the global market will grow at a CAGR of approximately 4.80% between 2025 and 2032.

Based on Product segmentation, the allograft segment dominates the market in 2025.

According to the application segment, Plastic surgery and wound healing are expected to experience significant CAGR growth during the forecast period.

North America is anticipated to lead the market in 2025.

Bioprosthetics Market- Segmentation Analysis:

The Global Bioprosthetics Market is segmented on the basis of Product, Application, and Region.

The market is divided into two categories based on Product: Allograft, and Xenograft. The allograft segment will dominate the market in 2025, owing to an increasing geriatric population and advances in allograft procedures. An allograft is a tissue or organ transplant from one individual to another of the same species. The world's aging population is contributing to an increase in CVD, necessitating tissue repair. The allograft prosthesis stands out for its excellent implant survival and functional performance, which improves long-term outcomes. For instance, Artivion, Inc.'s CryoValve AORTIC ALLOGRAFT includes a complete aortic root as well as the attached anterior mitral leaflet, providing several surgical implantation options.

The market is divided into two categories based on application: Cardiovascular, and Plastic surgery & wound healing. The plastic surgery and wound healing segment is expected to grow at a significant CAGR during the forecast period, owing to increased demand for minimally invasive surgery and technological advancement. According to the American Society of Plastic Surgeons (ASPS), overall cosmetic procedures performed on men increased by 6%. Furthermore, implementing minimally invasive techniques is having a positive impact on segment growth. Furthermore, the 2023 ASPS Procedural Statistics show that overall growth in cosmetic surgery procedures has increased by 5% per year.

Bioprosthetics Market- Geographical Insights

In 2025, North America is expected to dominate the market. Factors driving this growth include rising cardiovascular disease rates and established healthcare facilities in the region. According to the Centers for Disease Control and Prevention, cardiovascular disease (CVD) remains a major public health concern in the United States, with one person dying from it every 33 seconds. This alarming statistic highlights the need for better bioprosthetic heart valve options in the cardiovascular sector. The U.S. market has significantly contributed to growth in North America. This is due to rising heart disease, increased healthcare spending, and key biopharma companies in the country. Furthermore, favorable reimbursement policies and significant R&D investments are expected to accelerate market growth.

The Asia Pacific region is expected to have the fastest CAGR during the forecast period. This rapid growth is driven by increased awareness of alternative treatments, rapidly developing healthcare infrastructure, and increased engagement in research and development in developing countries like India and China. Government initiatives in these countries aim to improve healthcare accessibility and quality, which supports regional growth potential. China's Healthy China 2030 plan aims to improve health and promote longevity. This may lead to increased adoption of advanced medical technologies, such as bioprosthetics.

Bioprosthetics Market- Competitive Landscape:

The bioprosthetics market is highly competitive, driven by technological innovation, material advancements, and rising demand for minimally invasive procedures. LeMaitre Vascular, Inc., Braile Biomedica, Medtronic, Rua Life Sciences Plc (Aortech International Plc.), and LivaNova PLC (Sorin Group) dominate the market with a diverse portfolio of bioprosthetic heart valves and vascular grafts. These companies compete by investing in R&D, making strategic acquisitions, and expanding globally to strengthen their market position. New companies and startups are also entering the market with innovative tissue-engineered implants and personalized bioprosthetic solutions. The growing use of transcatheter aortic valve replacement (TAVR), favorable regulatory approvals, and rising prevalence of cardiovascular and orthopedic conditions are increasing competition and accelerating innovation in the industry.

Recent Developments:

In December 2024, Meril Life Sciences, an Indian medical equipment company, recently introduced the Myval Octapro transcatheter heart valve (THV), which has received CE mark approval for transcatheter aortic valve replacement (TAVR).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPROSTHETICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL BIOPROSTHETICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROSTHETICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL BIOPROSTHETICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Bioprosthetics Market Overview

2. Executive Summary

3. Bioprosthetics Key Market Trends

4. Bioprosthetics Industry Study

5. Bioprosthetics Market: Impact of Escalating Geopolitical Tensions

6. Bioprosthetics Market Landscape

7. Bioprosthetics Market - By Product

8. Bioprosthetics Market - By Application

9. Bioprosthetics Market- By Geography

10. Key Vendor Analysis- Bioprosthetics Industry

11. 360 Degree AnalystView

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â